CRISPR

CRISPR1-dre-mir-731

ID
ZDB-CRISPR-200124-10
Name
CRISPR1-dre-mir-731
Previous Names
  • CRISPR1-mir731
Target
Sequence
5' - GGCTGACACGAAGTTCCCGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
Df(Chr08:mir462,mir731)zf3163 dre-mir-462, dre-mir-731
zf3567 dre-mir-731
Expression
Gene expression in Wild Types + CRISPR1-dre-mir-731
No data available
Phenotype
Phenotype resulting from CRISPR1-dre-mir-731
No data available
Phenotype of all Fish created by or utilizing CRISPR1-dre-mir-731
Phenotype Fish Conditions Figures
whole organism ppp3r1a expression increased amount, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
heart heart contraction decreased rate, abnormal dre-mir-731zf3567/zf3567 (AB) control Fig. 3Fig. 4 from Huang et al., 2022
heart reactive oxygen species increased distribution, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
whole organism Ab1-nfatc3 labeling increased amount, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
heart regulation of calcineurin-mediated signaling process quality, ameliorated dre-mir-731zf3567/zf3567 (AB) chemical treatment by environment: tacrolimus (anhydrous) Fig. 4 from Huang et al., 2022
heart regulation of calcineurin-mediated signaling increased process quality, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
brain reactive oxygen species increased distribution, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
whole organism dre-mir-731 expression decreased amount, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 1 from Huang et al., 2022
heart heart contraction rate, ameliorated dre-mir-731zf3567/zf3567 (AB) chemical treatment by environment: tacrolimus (anhydrous) Fig. 4 from Huang et al., 2022
heart heart looping process quality, ameliorated dre-mir-731zf3567/zf3567 (AB) chemical treatment by environment: tacrolimus (anhydrous) Fig. 4 from Huang et al., 2022
cardiac ventricle increased size, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 3 from Huang et al., 2022
heart heart looping decreased process quality, abnormal dre-mir-731zf3567/zf3567 (AB) control Fig. 3Fig. 4 from Huang et al., 2022
whole organism atp2a2a expression decreased amount, abnormal dre-mir-731zf3567/zf3567 (AB) standard conditions Fig. 4 from Huang et al., 2022
Citations